The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

Sign in to access this content
Sign InAurora Cannabis Inc. officially announced on April 15, 2026, the completion of its acquisition of Safari Flower Co. for an aggregate consideration of C$26.5 million. The transaction includes a mix of stock and cash, featuring a contingent cash payment of C$2 million based on the satisfaction of specific conditions, with the final price subject to customary adjustments. The deal provides Aurora with a sophisticated EU GMP-certified indoor cultivation facility in Ontario, designed to boost production for high-growth markets like Germany, Australia, and the UK. Management indicated that securing this infrastructure is key to capturing a larger share of the global medical cannabis sector. Analysts view the move as a bullish development for Aurora's supply chain efficiency and international scaling efforts. The integration of these assets is expected to strengthen Aurora's competitive positioning in premium global markets.